Publication | Closed Access
Venlafaxine exerts antidepressant effects possibly by activating MAPK–ERK1/2 and P13K–AKT pathways in the hippocampus
25
Citations
37
References
2017
Year
Molecular PharmacologyMolecular NeuroscienceAntidepressant EffectsPsychiatryNeurophysiologyMedicineP13k–akt PathwaysPsychotropic MedicationDepressionPsychopharmacologyNeuropharmacologyPharmacotherapyNeuroscienceBiological PsychiatryDopaminePharmacologySocial Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1